相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Identification of a prognostic gene signature of colon cancer using integrated bioinformatics analysis
Zhengyu Fang et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY (2021)
A 14-gene gemcitabine resistance gene signature is significantly associated with the prognosis of pancreatic cancer patients
Xing Wei et al.
SCIENTIFIC REPORTS (2021)
Biomarker-guided therapy for colorectal cancer: strength in complexity
Anita Sveen et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2020)
Patient-Derived Organoids Predict Chemoradiation Responses of Locally Advanced Rectal Cancer
Ye Yao et al.
CELL STEM CELL (2020)
5-fluorouracil and other fluoropyrimidines in colorectal cancer: Past, present and future
Sona Vodenkova et al.
PHARMACOLOGY & THERAPEUTICS (2020)
SEZ6L2 knockdown impairs tumour growth by promoting caspase-dependent apoptosis in colorectal cancer
Ning An et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2020)
Pharmacogenomics of 5-fluorouracil in colorectal cancer: review and update
Pan Xie et al.
CELLULAR ONCOLOGY (2020)
5-Fluorouracil resistance mechanisms in colorectal cancer: From classical pathways to promising processes
Sabrina Blondy et al.
CANCER SCIENCE (2020)
Network-based machine learning in colorectal and bladder organoid models predicts anti-cancer drug efficacy in patients
JungHo Kong et al.
NATURE COMMUNICATIONS (2020)
Organoids - Preclinical Models of Human Disease
Mo Li et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
TGF-β1 protects colon tumor cells from apoptosis through XAF1 suppression
Jung Rock Moon et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2019)
Tumor Mutation Burden and Prognosis in Patients with Colorectal Cancer Treated with Adjuvant Fluoropyrimidine and Oxaliplatin
Dae-Won Lee et al.
CLINICAL CANCER RESEARCH (2019)
Translational genomics and precision medicine: Moving from the lab to the clinic
Eleftheria Zeggini et al.
SCIENCE (2019)
A rectal cancer organoid platform to study individual responses to chemoradiation
Karuna Ganesh et al.
NATURE MEDICINE (2019)
Promising Colorectal Cancer Biomarkers for Precision Prevention and Therapy
Mimmo Turano et al.
CANCERS (2019)
ITGB4 is a novel prognostic factor in colon cancer
Meng Li et al.
JOURNAL OF CANCER (2019)
Individualized predictive signatures for 5-fluorouracil-based chemotherapy in right- and left-sided colon cancer
Kai Song et al.
CANCER SCIENCE (2018)
A Living Biobank of Breast Cancer Organoids Captures Disease Heterogeneity
Norman Sachs et al.
CELL (2018)
How many differentially expressed genes: A perspective from the comparison of genotypic and phenotypic distances
Bi Zhao et al.
GENOMICS (2018)
Patient-derived organoids model treatment response of metastatic gastrointestinal cancers
Georgios Vlachogiannis et al.
SCIENCE (2018)
Organoid Profiling Identifies Common Responders to Chemotherapy in Pancreatic Cancer
Herve Tiriac et al.
CANCER DISCOVERY (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Fructose-bisphosphate aldolase A is a key regulator of hypoxic adaptation in colorectal cancer cells and involved in treatment resistance and poor prognosis
Kenji Kawai et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2017)
Elevated expression of TrpC5 and GLUT1 is associated with chemoresistance in colorectal cancer
Teng Wang et al.
ONCOLOGY REPORTS (2017)
Human primary liver cancer-derived organoid cultures for disease modeling and drug screening
Laura Broutier et al.
NATURE MEDICINE (2017)
Personalized In Vitro and In Vivo Cancer Models to Guide Precision Medicine
Chantal Pauli et al.
CANCER DISCOVERY (2017)
Colorectal cancer statistics, 2017
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2017)
TCGAbiolinks: an R/Bioconductor package for integrative analysis of TCGA data
Antonio Colaprico et al.
NUCLEIC ACIDS RESEARCH (2016)
A Colorectal Tumor Organoid Library Demonstrates Progressive Loss of Niche Factor Requirements during Tumorigenesis
Masayuki Fujii et al.
CELL STEM CELL (2016)
Cell Line Derived 5-FU and Irinotecan Drug-Sensitivity Profiles Evaluated in Adjuvant Colon Cancer Trial Data
Ida Kappel Buhl et al.
PLOS ONE (2016)
DNA-Guided Precision Medicine for Cancer: A Case of Irrational Exuberance?
Emile E. Voest et al.
CANCER DISCOVERY (2016)
The biological complexity of colorectal cancer: insights into biomarkers for early detection and personalized care
Marina De Rosa et al.
THERAPEUTIC ADVANCES IN GASTROENTEROLOGY (2016)
Identification and Construction of Combinatory Cancer Hallmark-Based Gene Signature Sets to Predict Recurrence and Chemotherapy Benefit in Stage II Colorectal Cancer
Shanwu Gao et al.
JAMA ONCOLOGY (2016)
Profilin 2 promotes migration, invasion, and stemness of HT29 human colorectal cancer stem cells
Min-Jung Kim et al.
BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY (2015)
Prospective Derivation of a Living Organoid Biobank of Colorectal Cancer Patients
Marc van de Wetering et al.
CELL (2015)
Building the foundation for genomics in precision medicine
Samuel J. Aronson et al.
NATURE (2015)
TP53 loss creates therapeutic vulnerability in colorectal cancer
Yunhua Liu et al.
NATURE (2015)
limma powers differential expression analyses for RNA-sequencing and microarray studies
Matthew E. Ritchie et al.
NUCLEIC ACIDS RESEARCH (2015)
Genetics, diagnosis and management of colorectal cancer
Marina De Rosa et al.
ONCOLOGY REPORTS (2015)
Gene signatures of drug resistance predict patient survival in colorectal cancer
Y. Zheng et al.
PHARMACOGENOMICS JOURNAL (2015)
A 12-gene signature to distinguish colon cancer patients with better clinical outcome following treatment with 5-fluorouracil or FOLFIRI
Eric R. Paquet et al.
JOURNAL OF PATHOLOGY CLINICAL RESEARCH (2015)
Overcoming 5-Fu Resistance of Colon Cells through Inhibition of Glut1 by the Specific Inhibitor WZB117
Wei Liu et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2014)
Comparison of Tumor Regression Grade Systems for Locally Advanced Rectal Cancer After Multimodality Treatment
Atthaphorn Trakarnsanga et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2014)
Notch-induced transcription factors are predictive of survival and 5-fluorouracil response in colorectal cancer patients
P. A. Candy et al.
BRITISH JOURNAL OF CANCER (2013)
Colon and Rectal Cancer Survival by Tumor Location and Microsatellite Instability: The Colon Cancer Family Registry
Amanda I. Phipps et al.
DISEASES OF THE COLON & RECTUM (2013)
Chemoradiotherapy with capecitabine versus fluorouracil for locally advanced rectal cancer: a randomised, multicentre, non-inferiority, phase 3 trial
Ralf-Dieter Hofheinz et al.
LANCET ONCOLOGY (2012)
Comprehensive molecular characterization of human colon and rectal cancer
Donna M. Muzny et al.
NATURE (2012)
clusterProfiler: an R Package for Comparing Biological Themes Among Gene Clusters
Guangchuang Yu et al.
OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY (2012)
Clinical Value of Prognosis Gene Expression Signatures in Colorectal Cancer: A Systematic Review
Rebeca Sanz-Pamplona et al.
PLOS ONE (2012)
Target Gene Analysis by Microarrays and Chromatin Immunoprecipitation Identifies HEY Proteins as Highly Redundant bHLH Repressors
Julia Heisig et al.
PLOS GENETICS (2012)
Long-term Expansion of Epithelial Organoids From Human Colon, Adenoma, Adenocarcinoma, and Barrett's Epithelium
Toshiro Sato et al.
GASTROENTEROLOGY (2011)
Gene Expression Signature to Improve Prognosis Prediction of Stage II and III Colorectal Cancer
Ramon Salazar et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Purposeful selection of variables in logistic regression
Zoran Bursac et al.
SOURCE CODE FOR BIOLOGY AND MEDICINE (2008)
TIMP-1 is significantly associated with objective response and survival in metastatic colorectal cancer patients receiving combination of irinotecan, 5-fluorouracil, and folinic acid
Nanna M. Sorensen et al.
CLINICAL CANCER RESEARCH (2007)
Relaxing the rule of ten events per variable in logistic and Cox regression
Eric Vittinghoff et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2007)
Cellular response to 5-fluorouracil (5-FU) in 5-FU-resistant colon cancer cell lines during treatment and recovery
Paula M. De Angelis et al.
MOLECULAR CANCER (2006)
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
A Subramanian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
The prognostic significance of K-ras, p53, and APC mutations in colorectal carcinoma
A Conlin et al.
GUT (2005)
Epigenetic inactivation of class II transactivator (CIITA) is associated with the absence of interferon-γ-induced HLA-DR expression in colorectal and gastric cancer cells
A Satoh et al.
ONCOGENE (2004)
Membrane transporters and channels:: Role of the transportome in cancer chemosensitivity and chemoresistance
Y Huang et al.
CANCER RESEARCH (2004)
Preoperative versus postoperative chemoradiotherapy for rectal cancer
R Sauer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Apoptotic response to 5-fluorouracil treatment is mediated by reduced polyamines, non-autocrine Fas ligand and induced tumor necrosis factor receptor 2
W Zhang et al.
CANCER BIOLOGY & THERAPY (2003)
Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial
JY Douillard et al.
LANCET (2000)
分享论文
